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ABSTRACT 
Mass spectrometry provides exquisite detail on ligand and cation binding stoichiometries with a 
DNA target. The next important step is to develop reliable methods to determine the cation and 
ligand binding sites in each complex separated by the mass spectrometer. To circumvent the 
caveat of ligand derivatization for cross-linking, which may alter the ligand binding mode, we 
explored a tandem mass spectrometry (MS/MS) method that does not require ligand 
derivatization, and is therefore also applicable to localize metal cations. By obtaining more 
negative charge states for the complexes using supercharging agents, and by creating radical 
ions by electron photodetachment, oligonucleotide bonds become weaker than the DNA-cation 
or DNA-ligand noncovalent bonds upon collision-induced dissociation of the radicals. This 
electron photodetachment (EPD) method allows to locate the binding regions of cations and 
ligands by top-down sequencing of the oligonucleotide target. The very potent G-quadruplex 
ligands 360A and PhenDC3 were found to replace a potassium cation and bind close to the central 
loop of 4-repeat human telomeric sequences. 
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INTRODUCTION 
 
In the presence of physiologically relevant cations such as potassium, guanine-rich repeated 
sequences can form G-quadruplex structures owing to the formation of guanine quartets, which 
pile up thanks to monovalent cation coordination in-between them (Figure 1).1 Sequences having 
at least four G-rich regions can form a variety of intramolecular G-quadruplex topologies, as the 
three loops linking the G-tracts can adopt no less than 14 different combinations of lateral, 
diagonal, or edgewise positioning.2, 3 This structural polymorphism is what renders G-quadruplex 
structural studies difficult. The polymorphism is particularly acute for the human telomeric motif,  
constituted by repetitive (TTAGGG)n sequences, because the 3-nt loops (TTA) are compatible 
with edgewise, lateral and diagonal position, and thus multiple topologies are possible.4-8 
Moreover, these conformations are relatively close in energy, and minor changes in the sequence 
(e.g., addition or deletion of terminal bases4, 7) or in the solution conditions (e.g., the nature 
monovalent cations present,8 or the presence of non-aqueous additives9, 10) can switch the 
conformational equilibria from one topology to another. Finally, structures with two G-quartets can 
be formed alongside those having three G-quartets.11, 12  
 
G-quadruplex formation can influence important cellular processes such as gene expression 
(particularly for oncogenes),13 splicing,14 or telomere maintenance.15, 16 The search for ligands 
able to bind specifically to particular G-quadruplexes is therefore a very active field of research, 
either for therapeutic aims17-19 or to probe G-quadruplex presence.20 The rational design of drugs 
targeting G-quadruplexes is also hampered by the fact that organic molecules can also shift 
conformational equilibria. In the context of G-quadruplex ligand design, it is important to 
characterize experimentally not only ligand binding affinities, but also ligand binding modes 
including ligand-induced conformational changes.  
 
We have previously demonstrated using mass spectrometry (MS) and circular dichroism (CD) 
spectroscopy that the high-affinity G-quadruplex ligands PhenDC3 and 360A (Figure 1D) change 
the conformation of the human telomeric G-quadruplexes by ejecting a cation upon binding: the 
major DNA(M):ligand(L):cation(K) stoichiometry is 1:1:1 (the complex is noted “MLK”), despite in 
the same conditions without ligand the main DNA:cation stoichiometry is 1:2 (complex “MK2”).21-
23 However, the ligand binding site, (i.e. the G-quartet), cannot be determined by simple MS 
experiments. Here, we used mass spectrometry to select complexes of well-defined cation and 
ligand binding stoichiometries, and explored a top-down fragmentation approach (i.e. 
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fragmentation of the intact complex) to locate the non-covalently bound cations and ligands on 
the target sequences. 
   
Figure 1. A) G-quadruplex DNA forming sequences studied here. B) Hydrogen bonding 
pattern in a guanine quartet. C) Schematic topology adopted by the sequences 22GT and 
23TAG, as reported from solution NMR (PDB accession codes: for 22GT:2KF811, for 
23TAG: 2JSM24), and supposed potassium ion locations, sandwiched in-between the G-
quartets. White grey rectangles are guanines in anti conformation, and red rectangles are 
guanines in syn conformation. D) Chemical structures of the ligands studied herein.  
To reliably locate a noncovalently bound ligand on a DNA sequence using tandem mass 
spectrometry (MS/MS), ligand-DNA bonds must not break while the DNA backbone must 
fragment at multiple positions to obtain full sequence coverage. This objective is identical as for 
the localization of fragile post-translational modifications on proteins25 Two approaches (which 
can be combined) maximize the chances of success: (1) reinforcing the bonds between the 
noncovalent ligand and the DNA, and (2) weakening the DNA backbone to favor chain 
fragmentation.  
 
In electrospray ionization (ESI) mass spectrometry, nucleic acids spray well in the negative ion 
mode, and most high-affinity DNA ligands are positively charged, so ligand-DNA ionic interactions 
are actually reinforced in the desolvated ions compared to in solution, and may persist even under 
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the CID (collision-induced dissociation) conditions required to fragment the DNA backbone. This 
property has been exploited to characterize aminoglycoside binding to RNA26 and tat peptide 
binding to TAR RNA27 by CID. Another way to reinforce bonds is to derivatize the ligand with an 
alkylating agent that will irreversibly bind to DNA bases accessible from the binding site. To 
accurately reflect the ligand binding properties, the derivatization must not perturb the binding site 
and the conformational equilibria. The alkylated base(s) can then be mapped by gel 
electrophoresis, or by MS/MS. The widespread collision-induced dissociation MS/MS technique 
typically leads to fragmentation into w and a-Base ions (Figure 2A,B).28 
 
Figure 2. A) Fragment ion nomenclature for oligonucleotides. B) Typical fragments 
encountered in collision-induced dissociation (CID) of closed-shell DNA: an-B (with 
loss of base n from fragment an) and wN-n, and schematic annotations for CID 
sequencing (n indicates fragmentation after the nth base, and N is the total number 
of bases in the oligonucleotide). C) The electron photodetachment dissociation 
(EPD) process (CID on radicals created by UV irradiation), typical fragments (an●, 
wN-n, dn and zN-n●) observed in EPD of oligonucleotides, and schematic annotations 
for EPD sequencing. 
The second approach is to use alternative MS/MS activation techniques that weaken the DNA 
backbone. Typically, radical ions are less stable than their corresponding closed-shell ions, and 
sequence coverage is more extensive from radicals. In proteins, creating radicals by electron 
capture dissociation (ECD) or electron transfer dissociation (ETD) are widely used in top-down 
sequencing of multiply charged cations, and these approaches have been used to locate cation29 
or ligand binding sites.30-33 Nucleic acids, however, are best ionized as multiply charged anions. 
Radicals are therefore more easily accessed by electron detachment.34 Irradiation of DNA multiply 
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charged anions with UV light (235-280 nm) is particularly efficient to detach electrons.35 A recent 
systematic study on 6-mer single strands shows that the competition between electron 
photodetachment (ePD) and fragmentation (UVMPD) is base-dependent, and that electron 
photodetachment is particularly efficient for guanines.36 However, for longer strands, UVMPD 
becomes inefficient, most probably because of the competing collisional cooling by the helium in 
the quadrupole ion trap, and further activation is required to obtain fragments. The radicals 
generated can thus be selected in an MS3 step and fragmented by CID. The whole process, 
illustrated in Figure 2C, has been coined electron photodetachment dissociation (EPD).37  
 
EPD sequencing has been demonstrated first for DNA, with complete coverage for single 
strands up to 15 nucleotides,37 and then has been applied to proteins,38 carbohydrates, and 
synthetic polymers.39 This method is appealing for characterizing non-covalent interactions 
between ligands and G-quadruplexes because (i) G-quadruplexes ionize well in negative mode 
and the presence of several guanines ensures efficient photodetachment, and (ii) electron 
photodetachment is soft and the structure of the complexes is likely preserved during that step. 
The challenge here is to obtain as complete sequence coverage as possible on sequences longer 
than 20 nucleotides, and to validate that the cations and ligands do not shuffle before the 
fragments separate at the MS3 step. Here, we explored whether EPD could provide information 
on the cation and ligand binding sites on the G-quadruplexes, with particular focus on 
characterizing the peculiar binding mode of PhenDC3 and 360A to telomeric G-quadruplexes. We 
found that these ligands bind close to the central loop of the quadruplexes, and validated this 
result with a covalent derivative.  
 
MATERIALS AND METHODS 
 
Samples. All oligonucleotides were purchased from Eurogentec (Seraing, Belgium) in 
lyophilized form and with RP-cartridge-Gold purification. They were solubilized in nuclease-free 
grade water (Ambion, Fisher Scientific, Illkirch, France) at approximately 200 µM. The 
concentrations were measured using absorbance at 260 nm on a Uvikon XS and molar extinction 
coefficients calculated using the online Integrated DNA Technologies OligoAnalyzer tool using 
Cavaluzzi-Borer Correction.40 Final solutions at the exact desired concentrations were prepared 
in nuclease-free grade water with trimethylammonium acetate (TMAA, Ultra for UPLC, Fluka) and 
potassium chloride (KCl, >99.999%, Sigma) purchased from Sigma-Aldrich (Saint-Quentin 
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Fallavier, France). The experiments were carried out on the sequences 22GT and 23TAG (Figure 
1A), which predominantly adopt specific topologies in KCl solution (Figure 1C). These sequences 
were prepared in 0.2 mM to 1.0 mM KCl and 100 mM trimethylammonium acetate (TMAA) 
solutions, which mimic physiological ionic strength, ensure K+ presence to fold the G-
quadruplexes, and are compatible with electrospray ionization mass spectrometry.41 The 
synthesis of the covalent binder analogues is described in the supplementary information.  
 
Mass spectrometry and electron photodetachment dissociation (EPD). ESI-MS, MS/MS 
and MS3 experiments were carried out on a Bruker Amazon SL quadrupole ion trap mass 
spectrometer (Bruker Daltonics, Bremen, Germany) modified to allow a laser beam to make a 
single pass through the center of the trap. The electrospray source conditions were 3000 V on 
the capillary, 500 V on the end plate offset, 7.2 psi on the nebulizer, and 3.5 L/min and 180 0C on 
the dry gas and dry temperature, respectively. Each mass spectrum was recorded for 10 minutes, 
and over 40 minutes were averaged to construct each EPD spectrum. A PREMISCAN/500/MB 
OPO with UV scan (GWU, Erftstadt, Germany), pumped by a Quanta-Ray PRO-230-30 Nd:YAG 
laser (Spectra Physics, Santa Clara, USA), was used to produce ~2 mJ/pulse at 240 nm and 30 
Hz. This wavelength was chosen to maximize electron photodetachment, but note that any 
wavelength in the base absorption region (~235-280 nm) would produce EPD as well. The EPD 
experiments were carried out by synchronizing a mechanical shutter opening with the activation 
time (100 ms, i.e. 3 laser shots) of the MS2 event. The laser beam (typical energy: ~1mJ/pulse at 
the vacuum chamber window) was focused on the ion cloud by a lens of 700 mm focal length. 
Three laser pulses per duty cycle were used to produce radical anions at 0V CID activation 
amplitude. The resulting radical anions were mass-isolated (MS3 stage, 4 m/z window) and 
subjected to collision-induced dissociation (typically: 1.2 V). The instrument was operated in 
negative ion mode (capillary voltage 3000 V, capillary exit -140 V). The syringe pump flow rate 
was 180 µL/h. EPD spectra were extracted using Data Analysis (Bruker Daltonics) software and 
interpreted manually.  
 
Ion mobility spectrometry. Ion mobility (ESI-IM-MS) experiments were carried out on an 
Agilent 6560 IMS-Q-TOF (Agilent Technologies, Santa Clara, USA) operated with helium in the 
linear drift tube IM. The dual-ESI source was operated in the negative ion mode. The syringe 
pump flow rate was 180 µL/h. The instrument is equipped with the “Alternate Gas Option”, wherein 
capacitance diaphragm gauges are connected to the trapping funnel and to the drift tube, and an 
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additional flow controller admits gas in the trapping funnel, and the flow controller is regulated by 
a feedback reading of the pressure in the drift tube. An in-house modification to the pumping 
system allows faster equilibration of the pressures: a second Tri-scroll 800 pump (Agilent) was 
connected to the source region (with an Edwards SP16K connected to the front pumping line), 
while the original Tri-scroll 800 pump is connected to the Q-TOF region. For all measurements, 
the helium pressure in the drift tube was 3.89 ± 0.01 Torr, and the pressure in the trapping funnel 
is 3.67 ± 0.01 Torr. The source temperature and fragmentor voltage were set at 200°C and 350V. 
The RF of the high pressure funnel and trapping funnel were set to 200 V and 210 V respectively. 
To ensure soft trapping condition, the trap entrance grid delta was set to 6 V.  
 
RESULTS AND DISCUSSION 
 
A typical ESI-MS spectrum obtained for 10 µM 23TAG in 0.2 mM KCl/100 mM TMAA is shown 
in Figure 3A: at this KCl concentration, the free DNA (M) and the complexes with one or two 
potassium ions (MK and MK2) coexist in approximately equal proportions. This KCl concentration 
was chosen so that, according to the equilibrium constants of potassium binding to the 23TAG 
sequence,42 both the unfolded form (M) and the two folded forms (MK and MK2) are visible, and 
nonspecific adducts are minimal. In 1 mM KCl, the complex MK2 becomes predominant 
(supporting Figure S1). The main charge states are 4- and 5-. When 10 µM ligand PhenDC3 is 
added to the 1 mM KCl solution of 23TAG, the major complex formed is however MKL (Figure 
3B): the ligand displaces one potassium ion. This ligand-induced K+ replacement is observed for 
all sequences and ligands studied here (supporting Figure S2). 
 
CID and EPD experiments were all carried out on a quadrupole ion trap instrument modified 
to couple and synchronize a wavelength-tunable laser operated at 240 nm. All EPD experiments 
starting with the 5- charge state of the 22-mers resulted in poor sequence coverage (supporting 
Figure S3): the Coulomb repulsion in the M4-● radical produced at the MS2 step is not sufficient to 
separate the fragments in the MS3 step. EPD experiments must be performed on higher charge 
to start with, but the 6- charge state produced from 100 mM TMAA (or the more typically used 
100 mM NH4OAc) solutions of the 22/23-mers is not abundant enough to produce EPD spectra 
with sufficient signal-to-noise ratio.  
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To increase the abundance of higher charge states, we used “supercharging” additives such 
as meta-nitrobenzylalcohol (m-NBA) or sulfolane, which increase the net charge of protein cations 
and nucleic acid anions.43-47 All EPD results were obtained with addition of 0.75% volume 
sulfolane. Importantly, we were concerned that supercharging could also disrupt the complex 
structure and affect the ligand position before probing it by EPD. Therefore, we first verified by 
electronic circular dichroism spectroscopy that the sulfolane additive did not affect the folding of 
the complexes in solution (supporting Figure S4). We found no CD signal change, even at up to 
7.5% sulfolane in solution (an extreme situation that could occur upon droplet desolvation, due to 
the preferential evaporation of water), suggesting that sulfolane did not affect the G-quadruplex 
topology in solution.  
 
We used ion mobility spectrometry on the solutions prepared with 0.75% m-NBA or sulfolane 
to verify which charge states remain folded in the gas-phase prior to EPD, and which charge 
states were too high and caused unfolding already upon electrospray. The ion mobility analysis 
on sulfolane-doped solutions of 10 µM 23TAG + 0.2 mM KCl (ESI-MS spectrum in Figure 3C) and 
23TAG + 1 mM KCl + 10 µM ligand (Figure 3D) are shown in Figures 3E and 3F, respectively. 
The ion mobility results deserve a few comments. First, both the G-quadruplex folded forms (MK 
and MK2) and the nonfolded form (M) adopt compact gas-phase conformations when produced 
at charge states 4- to 6-. Actually, for charge state 5-, the nonfolded form is more compact in the 
gas phase than the G-quadruplex forms. At charge state 7-, the nonfolded form M is mostly 
extended in the gas phase, while a fraction of the G-quadruplexes (especially MK2) remains 
partially compact. We interpret this behavior as resulting from the balance between Coulomb 
repulsion and intramolecular noncovalent bonds. At charge state 5-, the Coulomb repulsion is not 
large enough to compensate for the nonspecific hydrogen bonds that can form between the polar 
and charged groups of single strands, let alone for the specific G-quadruplex bonds. The gas-
phase compaction at low charge states was discussed before for DNA single strands,48 DNA and 
RNA duplexes,49 and DNA i-motifs.50 At charge state 7-, the nonspecific interactions of the 
nonfolded forms are mostly broken, whereas those of the G-quadruplex persist up to higher 
internal energies. Charge states 7- and higher can be obtained only with the addition of sulfolane. 
Given that sulfolane does not significantly denature the complexes in solution, we suppose that 
charging occurs first, and then upon removal of the last solvent molecules the dielectric constant 
decreases and Coulomb repulsion unfolds the strands in the gas phase. 
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Similar ion mobility results were obtained for all sequences and ligands. Interestingly, the 
complexes at the charge state 6- remain compact in the gas phase (same collision cross section 
as the 5- charge state) in all cases.  To take no risk, we used only ions of the 6- charge state for 
probing by EPD, and therefore analyzed the fragments of the 5-● ions.  
 
EPD was carried out first for the complexes with potassium ions. The EPD results for 22GT 
without potassium (unfolded) show complete sequence coverage (Figure 4A), in contrast with 
regular CID (Supporting Figure S5), where cleavages on the 3’ side of thymines are often 
missed.28 However, when one potassium ion is bound to 22GT, a portion of the sequence around 
the central loop (from G9 to G14) is protected from fragmentation (Figure 4C). This also 
corresponds to the exclusive zone where the potassium ion remains attached upon fragmentation: 
K+ is not detected on 5’-terminal fragments equal to or shorter than a8•z-, and always detected on 
fragments equal to or longer than a14•z-. Complementarily, potassium is not detected on 3’-terminal 
fragments up to w8z- and are detected starting at w15z-.   
 
Importantly, the fragmentation of the potassium complex of a control sequence not able to form 
G-quadruplexes (the potassium adduct has therefore no specific location), gives (1) no such 
protection and (2) a more random positioning of the K+ on the fragments (Figure 4B: a high 
proportion of fragments are detected both with and without K+ bound). The protection and 
particular K+ location is therefore a tenet of the quadruplex fold.  
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Figure 3. A) ESI-MS spectrum of 10 µM 23TAG in 0.2 mM KCl/100 mM TMAA. B) 
ESI-MS spectrum of 10 µM 23TAG + 10 µM PhenDC3 in 1.0 mM KCl/100 mM 
TMAA. C-D) ESI-MS spectra of the same solutions as A-B, with 0.75% (vol) 
sulfolane added. E-F) Bi-dimensional separation (mass spectrometry on x-axis 
and ion mobility drift time separation on y-axis) of spectra C-D. The arrival time 
following drift tube separation is proportional to CCS/z (CCS = collision cross 
section). Charge state distributions having the same CCS are therefore found on 
diagonals. Ions of the most compact conformations travel faster.  
The 22GT sequence is known to fold into a 2-quartet structure formed by G1-G14-G20-G8 and 
G2-G15-G19-G7. The potassium ion is octa-coordinated between these eight guanine residues. 
The results therefore suggest that either potassium precludes radical-induced fragmentation at 
the backbone close to the loop region (but there is no clear rationale for that), or that the fragments 
formed after backbone cleavage around the central loop cannot separate in the CID activation 
conditions wherein the other bonds easily break. This is plausible because separating the 
fragments following cleavage at the central loop involves breaking more K+-guanine coordination 
bonds than separating the fragments following cleavage of the other loops (4 bonds versus 2 
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bonds). For the observed fragments, the potassium ions always stay on the longer fragment, 
possibly because they remain coordinated to guanine triplets. EPD of the complex of 22GT with 
two potassium ions shows a similar protection and location (G8 to G14) of both K+ ions close to 
the central loop (Figure 4D). This is in line with the intuitive anticipation that the additional K+ 
binding site resides between the G1-G14-G20-G8 quartet and the G9-G13-G21 triplet. Results 
for 23TAG were similar (Supporting Figure S6): for example, for the MK2 complex, protection and 
K+ location was at the exact same central sequence GGTTAGG (Figure 5A). However, given that 
cation coordination involves multiple bases (eight per cation), it is not possible to pinpoint a 
precise cation location on G-quadruplexes using EPD.  
 
Figure 4. A) EPD analysis of 22GT without potassium ion bound (M6-). B) EPD of 
the nonspecific MK6- complex of a control strand not forming G-quadruplex. EPD 
of 22GT G-quadruplex with one (C) potassium (MK6-) or with (D) two potassium 
ions bound (MK26-). Fragment schematic nomenclature is defined in Figure 2; and 
key numbering in panel C. 
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EPD analysis was then carried out on the complexes with the noncovalently bound ligands 
360A and PhenDC3. The complexes MKL fragment very similarly to the MK2 complexes (Figure 
5 B-C for M = 23TAG; Supporting Figure S7 for 22GT): both L and K+ were detected on fragments 
including the central G10GTTAGG16 sequence, and never on fragments not including that 
sequence. This holds both for 360A and PhenDC3. Ligand binding close to the central loop is 
compatible with several complex topologies (Figure 5E) and allows to exclude others (Figure 5F). 
Thus, although the protection of a 7-nt stretch from fragmentation due to the complex formation 
precludes a precise location of the ligand, EPD provides useful information to outline which 
binding topologies are plausible or not for each complex.  
 
 
Figure 5. MS/MS of the complexes with 23TAG. A) EPD analysis of the MK26- 
complex. EPD analysis of the MKL6- complexes with PhenDC3 (B) and 360A (C). 
D) CID analysis of the MKL6- complex with cross-linked PDC-C4-C. In B—D, the 
violet triangles represent the ligand. On the right are represented the 2-quartet 
antiparallel complex topologies that are compatible (E) or incompatible (F) with 
ligand location close to the central loop.   
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To validate the central loop ligand location obtained by EPD of the noncovalent complex, we 
compared the results with the alkylating approach. To this aim, chlorambucil derivatives of 
PhenDC3 and 360A were synthesized (Figure 1D for PDC-C4-C and supporting information for 
more detail). Chlorambucil has two electrophilic sites and may induce both mono- and bis-
alkylation on DNA, reacting mainly with the N7 of the guanines.51, 52 The ligands were allowed to 
react with their target (G-quadruplex pre-folded in 1 mM KCl) at room temperature for 24 hours. 
MS analysis highlights one of the main caveats of the cross-linking approach: the chlorambucil 
derivatives do not bind their target DNA with the same affinity as the original noncovalent ligands: 
PhenDC3-C4-C binds >100 times more poorly than PhenDC3, and PDC-C4-C binds with 10-fold 
lower affinity than 360A (Supporting Figure S8). PDC-C4-C binds exclusively by producing DNA 
mono-alkylation (loss of one HCl molecule) and ejection of one potassium ion (the MLK complex 
predominates, see Supporting Figure S9). So, despite the lower affinity of PDC-C4-C to G4, we 
assume that its binding mode is similar to that of 360A.  
 
EPD analysis was not feasible on the MLK complex of PDC-C4-C: as the ligand binds by mono-
alkylation, one chlorine group remains in the complex; as a result, the 5-● ions fragment 
exclusively by chlorine radical loss. CID was therefore performed on the 5- and 6- ions with 22GT 
and 23TAG (supporting Figure S10). The detected fragments are summarized in Figure 5D for 
the MLK6- complex with 23TAG. The shortest 5’-terminal fragment on which L is detected is a15-
Base, and given that the lost base is G15, it means that L is located somewhere on the first 14 
bases. Similarly, the shortest 3’-fragment containing L is w12z- (complementary to a11z-). This 
allows to bracket the cross-linking site on the central TTA loop.  
 
Given the preferred reactivity of chlorambucil to guanines, binding to the loop sounds unusual. 
In a previous report, Balasubramanian group reported alkylation of a close analogue (pyridostatin-
chlorambucil conjugate)53 to telomeric DNA, and detected after nuclease digestion that the ligand 
was covalently bound to both adenines and guanines. To confirm the MS/MS results, we 
performed gel sequencing analysis on PDC-C4-C adducts on the sequence 22AG 
(dAGGG(TTAGGG)3), the same as used by the Balasubramanian group. Alkaline treatment of 
the PDC-C4-C adducts revealed exclusive alkylation on thymine nucleobase localized within the 
central loop and on the two proximal guanines (Supporting Figure S11). All these results support 
the conclusions we had drawn from top-down EPD on the noncovalent underivatized complexes, 
namely that ligands of the PDC family are located close to the central loop of 4-repeat telomeric 
sequences.  
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CONCLUSIONS 
 
In summary, we have demonstrated how electron photodetachment dissociation (EPD), a top-
down mass spectrometry sequencing approach, can be used to determine noncovalent binding 
sites on nucleic acids. Because the method does not require ligand cross-linking, tedious ligand 
derivatization procedures and risks of modifying the ligand behavior are alleviated. Localization 
is also possible on binders that are impossible to derivatize (e.g., single cations). Importantly, with 
mass spectrometry, top-down analysis can be carried on each complex stoichiometry individually, 
even though a mixture of stoichiometries may exist in solution. Enabling EPD on higher-resolution 
mass spectrometers and automating the fragment annotation will increase the applicability of the 
technique to nucleic acid complex characterization, in a similar way as ECD or ETD have now 
become routine techniques to localize post-translational modification on proteins.  
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